Frailty In Patients Undergoing Vascular Surgery: A Narrative Review Of Current Evidence
- PMID: 31802876
- PMCID: PMC6802734
- DOI: 10.2147/TCRM.S217717
Frailty In Patients Undergoing Vascular Surgery: A Narrative Review Of Current Evidence
Abstract
Frailty is presumably associated with an elevated risk of postoperative mortality and adverse outcome in vascular surgery patients. The aim of our review was to identify possible methods for risk assessment and prehabilitation in order to improve recovery and postoperative outcome. The literature search was performed via PubMed, Embase, OvidSP, and the Cochrane Library. We collected papers published in peer-reviewed journals between 2001 and 2018. The selection criterion was the relationship between vascular surgery, frailty and postoperative outcome or mortality. A total number of 52 publications were included. Frailty increases the risk of non-home discharge independently of presence or absence of postoperative complications and it is related to a higher 30-day mortality and major morbidity. The modified Frailty Index showed significant association with elevated risk for post-interventional stroke, myocardial infarction, prolonged in-hospital stays and higher readmission rates. When adjusted for comorbidity and surgery type, frailty seems to impact medium-term survival (within 2 years). Preoperative physical exercising, avoidance of hypalbuminemia, psychological and cognitive training, maintenance of muscle strength, adequate perioperative nutrition, and management of smoking behaviours are leading to a reduced length of stay and a decreased incidence of readmission rate, thus improving the effectiveness of early rehabilitation. Pre-frailty is a dynamically changing state of the patient, capable of deteriorating or improving over time. With goal-directed preoperative interventions, the decline can be prevented.
Keywords: patient management; postoperative outcome; prehabilitation; preoperative risk assessment.
© 2019 Czobor et al.
Conflict of interest statement
This research did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors. AS reports being on a speaker bureau for GE Healthcare (for pediatric hemodynamic monitoring) and receiving a fee from Amomed for consultation about vazopressin. The authors report no other conflicts of interest in this work.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources